Regular Replacement Therapy as Prophylaxis In Severe Forms of Von Willebrand Disease: Initial Results From the Von Willebrand Disease Prophylaxis Network (VWD PN) Study Group

被引：0
|
作者：
Berntorp, Erik [1 ]
Abshire, Thomas C. [2 ]
Federici, Augusto B. [3 ]
机构：
[1] Lund Univ, Malmo Ctr Thrombosis & Haemostasis, Malmo, Sweden
[2] Blood Ctr Wisconsin, Milwaukee, WI USA
[3] Univ Milan, Dept Internal Med, Milan, Italy
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / 110
页数：2
相关论文
共 50 条
  • [41] Bleeding in Patients with Clinically Severe Von Willebrand Disease: Preliminary Results of Athn 9, a Natural History Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)
    Weyand, Angela C.
    Friedman, Kenneth D.
    Gupta, Sweta
    Haley, Kristina M.
    He, Chunla
    Pels, Salley
    Roberts, Jonathan C.
    Watson, Crystal
    Sidonio, Robert F., Jr.
    BLOOD, 2020, 136
  • [42] Clinical Study to Investigate the Efficacy and Safety of Wilate during Prophylaxis in Previously Treated Patients with Von Willebrand Disease (VWD)
    Sidonio, Robert F., Jr.
    Schwartz, Bruce A.
    BLOOD, 2019, 134
  • [43] Prophylaxis with recombinant von Willebrand factor in patients with type 3 von Willebrand disease: Results of a post hoc analysis from a phase 3 trial
    Leebeek, Frank W. G.
    Peyvandi, Flora
    Tiede, Andreas
    Castaman, Giancarlo
    Escobar, Miguel
    Wang, Michael
    Zulfikar, Bulent
    Susen, Sophie
    Miesbach, Wolfgang
    Wang, Scarlett
    Wang, Yi
    Zhang, Jingmei
    Ozen, Gulden
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (01) : 29 - 40
  • [44] Regular prophylaxis with a plasma-derived von Willebrand factor/factor VIII concentrate is effective for reducing nosebleeds in children and adults with von Willebrand disease
    Boban, A.
    Sidonio, R. F., Jr.
    Dubey, L.
    Vilchevska, K.
    Inati, A.
    Khayat, C. D.
    HAEMOPHILIA, 2024, 30 : 20 - 20
  • [45] Pregnancy complications and outcomes in women with moderate or severe von Willebrand disease (VWD)
    Turan, Ozlem
    HAEMOPHILIA, 2020, 26 : 138 - 139
  • [46] Outcomes of long-term von Willebrand factor prophylaxis use in von Willebrand disease: A systematic literature review
    El Alayli, Abdallah
    Petersen, Romina Brignardello
    Husainat, Nedaa M.
    Kalot, Mohamad A.
    Aljabiri, Yazan
    Turkmani, Hani
    Britt, Alec
    El-Khechen, Hussein
    Shahid, Shaneela
    Roller, John
    Motaghi, Shahrzad
    Mansour, Razan
    Tosetto, Alberto
    Abdul-Kadir, Rezan
    Laffan, Michael
    Weyand, Angela
    Leebeek, Frank W. G.
    Arapshian, Alice
    Kouides, Peter
    James, Paula
    Connell, Nathan T.
    Flood, Veronica H.
    Mustafa, Reem A.
    HAEMOPHILIA, 2022, 28 (03) : 373 - 387
  • [47] Gynaecological problem and their management in women with moderate and severe von Willebrand Disease (VWD)
    Turan, Ozlem
    HAEMOPHILIA, 2020, 26 : 139 - 140
  • [48] Prophylaxis and treatment of bleeding complications in von Willebrand disease type 3
    Berntorp, Erik
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2006, 32 (06): : 621 - 625
  • [49] The need for prophylaxis in von Willebrand's disease and other coagulation disorders
    Street, A
    Berntorp, E
    THROMBOSIS RESEARCH, 2006, 118 : S1 - S2
  • [50] The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study
    Seaman, Craig D.
    Ragni, Margaret V.
    Kouides, Peter A.
    Kraut, Eric H.
    Pruthi, Rajiv K.
    Raffini, Leslie J.
    Roberts, Jonathan C.
    von Drygalski, Annette
    Bellissimo, Daniel B.
    Brooks, Maria M.
    BLOOD, 2021, 138
12345